Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Evaluation of the Pharmacokinetics and Safety of Bupivacaine HCl Spinal Block and EXPAREL Local Infiltration in Subjects Undergoing for Unilateral Total Knee Arthroplasty

Next Previous
Trial Profile

Evaluation of the Pharmacokinetics and Safety of Bupivacaine HCl Spinal Block and EXPAREL Local Infiltration in Subjects Undergoing for Unilateral Total Knee Arthroplasty

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 09 Mar 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Bupivacaine (Primary)
  • Indications Anaesthesia; Postoperative pain
  • Focus Pharmacokinetics
  • Sponsors Pacira Pharmaceuticals

Most Recent Events

  • 19 Mar 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
  • 02 Dec 2014 Status changed from not yet recruiting to recruiting as per ClinicalTrials.gov record.
  • 02 Dec 2014 Planned End Date changed from 1 Feb 2015 to 1 May 2015 as per ClinicalTrials.gov record.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top